Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia

Single risk factors, such as hypertension and dyslipidemia, can combine to exacerbate the development and severity of cardiovascular disease. Treatment goals may be more effectively achieved if multiple disease factors are targeted with combination treatment. We enrolled 202 patients who were random...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xuan, Kim, Moo Hyun, Han, Ki Hoon, Hong, Soon Jun, Ahn, Jeong‐Cheon, Sung, Jung‐Hoon, Cho, Jin‐Man, Lee, Han Cheol, Choi, So‐Yeon, Lee, Kyounghoon, Kim, Woo‐Shik, Rhee, Moo‐Yong, Kim, Ju Han, Hong, Seung Pyo, Yoo, Byung Su, Cho, Eun Joo, Lee, Jae‐Hwan, Kim, Pum‐Joon, Park, Chang‐Gyu, Hyon, Min Su, Shin, Jin Ho, Lee, Sang Hyun, Sung, Ki Chul, Hwang, Jinyong, Kwon, Kihwan, Chae, In‐Ho, Seo, Jeong‐Sook, Kim, Hyungseop, Lee, Hana, Cho, Yoonhwa, Kim, Hyo‐Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Combination Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692919/
https://www.ncbi.nlm.nih.gov/pubmed/32937023
http://dx.doi.org/10.1111/jch.13893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692919/
https://www.ncbi.nlm.nih.gov/pubmed/32937023
http://dx.doi.org/10.1111/jch.13893

Ejemplares similares